LORI ALBRIGHT: Open Payments
NPI 1528309648 · PHILADELPHIA, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$922 in 61 payments from 12 companies in 2025. Trend: 2023 $167 · 2024 $488 · 2025 $922
Food & beverage: $922
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 31 | $389 |
| Axsome Therapeutics, Inc. | 10 | $139 |
| Collegium Pharmaceutical, Inc. | 3 | $63 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $60 |
| Neurocrine BioSciences, Inc. | 3 | $53 |
| Alkermes, Inc. | 2 | $43 |
| Lundbeck LLC | 2 | $37 |
| Braeburn Inc. | 2 | $35 |
| ABBVIE INC. | 2 | $32 |
| Teva Pharmaceuticals USA, Inc. | 1 | $29 |
Products named: CAPLYTA, Auvelity, Jornay PM, TRINTELLIX, INGREZZA, ARISTADA, REXULTI, BRIXADI.
Industry payments across PA — which companies pay providers there.
